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Abstract
Background: Impaired glucose tolerance (IGT) and high body mass index (BMI) are recognized risk factors for type
2 diabetes mellitus (T2DM). However, data suggest that also underweight predisposes people to develop T2DM.
Here, we experimentally tested if already moderate underweight is associated with impaired glucose tolerance as
compared to normal weight controls. Obese subjects were included as additional reference group.
Method: We included three groups of low weight, normal weight, and obese subjects comprising 15 healthy male
participants each. All participants underwent a standardized hyperinsulinemic-euglycemic glucose clamp
intervention to determine glucose tolerance. In addition, insulin sensitivity index (ISI) was calculated by established
equation.
Results: ISI values were higher in low and normal weight than in obese subjects (P < 0.010) without any difference
between low and normal weight groups (P = 0.303). Comparable to obese participants (P = 0.178), glucose
tolerance was found decreased in low weight as compared with normal weight subjects (P = 0.007). Pearson’s
correlation analysis revealed a positive relationship between glucose tolerance and BMI in low (P = 0.043) and
normal weight subjects (P = 0.021), an effect that was found inverse in obese participants (P = 0.028).
Conclusion: Our study demonstrates that not only obese but also healthy people with moderate underweight
display glucose intolerance. It is therefore suggested that all deviations from normal BMI may be accompanied by
an increased risk of developing T2DM in later life indicating that the maintenance of body weight within the
normal range has first priority in the prevention of this disease.
Background
Type 2 diabetes mellitus is a global epidemic. A consid-
erable body of evidence indicates that impaired glucose
tolerance and body mass index represent risk factors for
developing T2DM. To date, the association between
BMI and impaired glucose tolerance is well documented
in case of overweight and obesity [1] but little is known
about the relationship between low weight and IGT.
However, studies show a linear relationship between low
birth weight and the prevalence of T2DM in adult life
[2]. Moreover, IGT has been observed in severe malnu-
trition [3], certain forms of cancer [4], and anorexia ner-
vosa [5], i.e. diseases accompanied by extremely low
BMI within the scope of a pathologic state. These find-
ings indicate that, apart from obesity, also a BMI <
20 kg/m2 may be associated with IGT and therefore
with an increased risk of T2DM.
Against this background, we hypothesized that, in ana-
logy to obese subjects, also healthy individuals with
moderate underweight display IGT. In order to test this
hypothesis, we investigated whether glucose disposal
rates, giving key information about glucose tolerance,
and calculated insulin sensitivity by insulin sensitivity
index (ISI) differ between low weight, normal weight,
and obese healthy young men during a glucose clamp
experiment which is considered as ‘gold standard’
method in this context in diabetes research [6].
A hyperinsulinemic-euglycemic clamp places plasma
glucose concentration under the investigator’s control
and thus breaks the endogenous glucose-insulin feed-
back loop. The technique consists of an insulin infusion
at predetermined fixed dosage and a variable glucose
infusion rate. Under steady-state conditions of euglyce-
mia, the glucose infusion rate equals glucose uptake by
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all tissues in the body [6] and is therefore a measure of
glucose tolerance [7].
Methods
We studied 15 low weight (BMI between 17.6 and
19.8 kg/m2; mean 18.97 ± 0.20 kg/m2), 15 normal
weight (BMI between 20.2 and 23.5 kg/m2; mean
21.86 ± 0.30 kg/m2), and 15 obese (BMI between
30.1 and 43.6 kg/m2; mean 33.81 ± 1.10 kg/m2) male
volunteers aged 18-30 years. All subjects had a regular
sleep-wake cycle during the week before the experi-
ments. Exclusion criteria were acute or chronic illness,
diabetes in 1-degree family members, alcohol or drug
abuse, smoking, competitive sports, shift work, excep-
tional physical or mental stress, and any kind of current
medication. The study conformed to the Declaration of
Helsinki and was approved by the Ethics Committee on
Research Involving Humans of the University of
Luebeck. All subjects gave written informed consent.
After an overnight fast of 12 hours, subjects arrived at
the research unit at 8:00 a.m. One cannula was inserted
into a peripheral vein on the back of the hand and a sec-
ond cannula into an antecubital vein of the contralateral
arm. The first blood sample was taken at 8:30 a.m. to
determine baseline concentrations of circulating glucose
and insulin. At 8:40 a.m., the glucose clamp was started by
administration of an insulin bolus (H-insulin, Hoechst,
Frankfurt, Germany) of 5 mU/kg body weight (BW)/min
over 2 min. Thereafter, insulin was infused at a constant
rate of 1.5 mU/kgBW/min until the end of the clamp.
A 20% glucose solution was infused simultaneously at a
variable rate to maintain plasma glucose values at approxi-
mately 5.5 mmol/l for 45 minutes. Thereafter, insulin infu-
sion was stopped, and plasma glucose concentrations were
normalized by increasing glucose infusion rates.
Blood samples were drawn at 5-minute intervals to
measure plasma glucose concentrations (B-Glucose-
Data-Management, HemoCue GmbH, Grossostheim,
Germany) and every 10 minutes for the determination
of hormones. Blood was centrifuged within 5 min after
withdrawal and serum as well as plasma was kept at
-72°C until assay.
Plasma glucose was measured by using the hexokinase
method (Nichols Institute Diagnostics, Bad Vilbel,
Germany) with coefficient of variation (CV) smaller
than 4.2%. Serum insulin concentrations were measured
by commercial enzyme-linked immunoassay (Immulite,
DPC, Los Angeles, USA) with intra-assay CV < 5.2%
and inter-assay CV < 6.1%.
Values are presented as mean ± SEM. To test for the
criteria required for multivariate analyses, we performed
a Kolmogorov-Smirnov test on each variable. A Kolmo-
gorov-Smirnov P-value of .05 or greater was considered
as a normal distribution All continuous variables were
found normally distributed in each group (all Kolmo-
gorov-Smirnov Z > 0.432, all P > 0.500). Thus, statistical
analyses were based on analysis of variance for repeated
measurements (ANOVA) with the factors “time” (for
repeated measurements during the experiment) and
“group” (for differences between normal, low weight,
and obese participants). For pairwise comparisons
between groups, unpaired Student’s t-test was used. ISI
was calculated as described by Eriksson et al. [8] and
respective P-values were revealed by one-way ANOVA.
Correlation analyses were performed by bivariate corre-
lation analysis according to Pearson. A P-value less than
0.05 was considered significant.
Results
As shown in Figure 1A, plasma glucose concentrations
did not differ between low weight, normal weight, and
obese subjects throughout the experiments (all P >
0.114 for group effect; all P > 0.409 for group by time
Figure 1 Plasma glucose, glucose infusion rates, and insulin
concentrations. Mean ± SEM concentrations of plasma glucose (A),
glucose infusion rates (B), and serum insulin (smart insert in Fig. 1A)
during hyperinsulinemic-euglycemic clamp experiments in groups
of low weight (open cycles), normal weight (gray cycles), and obese
(black cycles) men (n = 15 per group).
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interaction). Glucose infusion rates required to maintain
target glucose values during the clamp were significantly
decreased in low as compared with normal weight sub-
jects (123.9 ± 12.2 vs. 182.4 ± 19.3 ml/h; P = 0.007 for
group effect; P = 0.002 for group by time interaction,
Figure 1B) and showed no differences in comparison to
the obese group (150.6 ± 20.7 ml/h; P = 0.178 for group
effect; P = 0.201 for group by time interaction). Addi-
tional correlation analyses revealed a positive relation
between glucose infusion rates and BMI in low and nor-
mal weight subjects (r = 0.529; P = 0.043, Figure 2A and
r = 0.587; P = 0.021, Figure 2B, respectively; cumulative:
r = 0.680; P < 0.001), i.e. between BMI and glucose
tolerance, which was found inverse in obese subjects
(r = -0.564; P = 0.028; Figure 2C).
Baseline serum insulin concentrations were significantly
higher in obese as compared with low and normal weight
subjects (87.43 ± 8.95 vs. 42.88 ± 16.33 and 44.28 ±
12.14 pmol/l, respectively; all P < 0.027), while there was
no difference in insulin values between the low and nor-
mal weight groups (P = 0.946; small insert in Figure 1A).
During the hyperinsulinemic-euglycemic clamp, serum
insulin concentrations increased in all groups with a sig-
nificantly dampened increase in low and normal weight
in comparison to obese participants (447.40 ± 42.13 and
486.55 ± 33.45 vs. 790.96 ± 74.72 pmol/l; all P <
0.001 for group effect; all P > 0.388 for group by time
interaction) and comparable insulin values in the low and
normal weight group (P = 0.594 for group effect; P =
0.591 for group by time interaction). Calculated ISI values
were significantly higher in low and normal weight than
in obese subjects (13.43 ± 1.57 and 17.82 ± 3.87 vs.
6.09 ± 1.09 mg*100*l*kg-1*min-1*mU-1; all P < 0.010)
without any difference between the low and normal
weight groups (P = 0.303).
Discussion
Our data demonstrate that moderate underweight is
associated with impaired glucose tolerance in healthy
human volunteers. While a relationship between obesity
and glucose intolerance is well known, our findings sug-
gest that generally all deviations from normal BMI may
be accompanied by an increased risk of developing
T2DM in later life. One could thus conclude that the
maintenance of body weight within the normal range
has first priority in the prevention of this disease.
To our knowledge, this is the first study that shows
significant associations between low weight and IGT
under metabolically well controlled conditions of a stan-
dardized glucose clamp. In our study, glucose infusion
rates required to maintain euglycemic glucose values
were significantly decreased in low weight as compared
with normal weight subjects but were comparable to
those measured in obese participants. Moreover, we
found a positive relation between BMI and glucose tol-
erance in low weight and normal weight subjects as well
as a negative correlation in obese participants. To date,
little is known about the relationship between low
weight and IGT in healthy subjects. Former studies
investigated glucose tolerance in patients with significant
underweight within the scope of a pathologic state. An
impairment of glucose tolerance has previously been
seen in patients with cancer [4,9,10]. Additionally, IGT
Figure 2 Correlation between glucose infusion rates and BMI.
Correlation analyses between glucose infusion rates and BMI in low
(open cycle; n = 15; Fig. 2A) and normal weight subjects (gray
cycles; n = 15; Fig. 2B) as well as in obese men (black cycles;
n = 15; Fig. 2C). Data show a positive correlation between BMI and
glucose tolerance in low and normal weight participants which was
found inverse in obese subjects.
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has also been found in middle-aged subjects with severe
chronic malnutrition [3] as well as in young women
with anorexia nervosa [5]. Moreover, studies in older
adults indicated an association between poor nutritional
status as well as hypomagnesaemia and risk of T2DM
[11-13]. These findings are in line with animal studies
showing that protein-energy restriction decreases
glucose-induced insulin secretion and worsens post-
receptor signaling of insulin [14]. Interestingly, such
impairment in glucose-induced insulin release has also
been seen in lean middle-aged and older patients with
T2DM [15] implicating that the here described impair-
ment of glucose tolerance in low weight young men
could be a consequence of decreased insulin sensitivity
in these subject. In our study, however, insulin concen-
trations as well as ISI were well comparable between
low weight and normal weight participants indicating
that BMI between 17.6 and 19.8 kg/m2 is not accompa-
nied by changes in insulin sensitivity.
Conclusions
In summary, we found a close association between IGT
and BMI equally in both low weight and obese partici-
pants. This finding is of high clinical relevance because
low weight in adults has been neglected as risk factor
for diabetes so far and the strong relationship suggests
that the prevention of obesity and low weight may be
crucial to overcome the increasing problem of T2DM.
In consequence, clinicians should consider the fact that
all subjects with deviations from normal BMI values,
regardless of their plasma glucose levels, may display
glucose intolerance and thereby could develop diabetes
in later life. Thus, also subjects with moderate under-
weight should be advised to normalize their BMI for
prevention.
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